!"#$%&'()'!"#$%#&'(&)(*+,(
"%-,".*%/.',(*&(0123(4567(
((((((((8.&-9,":9;&9;(
(
(
(
(
(
(
<=%;;.>"%#&'(
?+,.9(%"#$%#&'(.;(@:,(*&(
&A.@%#&'( &9( 9,@:"#&'B(
%C&'D(&*+,9(;.*:%#&';7(
Enzymatic or chemical
hydrolysis
!"#$%&'*7(E9&@9:D(/.'@(*&(%(*9%';-&9*%@&9(4067(
8.'@,@(*&(*9%';-&9*,9;(
(
(
(
(
(
(
(
(
(
(
F*(.;(*+,(-9,":9;&9(&)(%(
@9:DB( %@C.'.;*9%*,@(
G.*+.'( %'( .'%"#$,(
)&9C( /:*( *+9&:D+(
C,*%/&=."( -9&",;;,;(
G.==(/,("&'$,9*,@(.'*&(
*+,( -+%9C%"&=&D."%=(
C&=,":=,7((
EHIJH3KL(
J,>'.#&'(
?+,( =.-&-+.=."( @9:D(
G.==(/,(9,=,%;,@()&9((
%( /,M,9( :-*%N,(
%'@(@.;*9./:#&'7(
O&=,":=%9(C,"+%'.;C(&)(-9&@9:D;(
!"#$%&'+7(O&=,":=%9(C,"+%'.;C(&)(-%"=.*%A,=(4P67((
!"#$%&',7(O&=,":=%9(
C,"+%'.;C(&)(
D,C".*%/.',(4Q67(
!"#$%&'-.7(O&=,":=%9(C,"+%'.;C(&)("%-,".*%/.',(.'(*+,(",==(4RS67(
<%;-%;,(T(
E%"=.*%A,=(
EUP(O!E(N.'%;,(
EVR(
8%A( 8%@(
8"=1V((
8"=1V((
<%;-%;,(U( !-&-*&;.;(
(((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((((K,C".*%/.',(
(
(
(
(((E%"=.*%A,= ((
<%-,".*%/.',(
?+,W(%9,(@.X,9,'*(*W-,(&)(%'#"%'",9(-9&@9:D;Y(
!!'#C,*%/&=.*,((((((((;*&-(;W'*+,;.;(&)(JZ!(&9(/=&"N.'D(CHZ!():'"#&'7(
!!'#C.*&#"(((((((((((((((K,C".*%/.',(%'@(<%-,".*%/.',(
(((((((((((((((F'+./.*(*+,(@,-&=WC,9.[%#&'(&)(
((((((((((((((((C."9&*:/:=,(.'(",==(@.$.;.&'(
(((((((((((((((E%"=.*%A,=(
!@$%'*%D,;(
"((L&=:/.=.*W(
"((!/;&9-#&'(
"((O,*%/&=.;C(
"?.;;:,(;-,".>"(
/012302&%'4%56%$#78'9:&'0&;';3<''
5='$7"0#'030543%12>&7'
!"#$%&'-7(?+,(+%==C%9N;(&)("%'",9(4R67(
Universitat Autònoma de Barcelona
!<%'",9(.;(%(@.;,%;,(G.*+(%(+.D+(C&9*%=.*W(9%*,(G+."+(/9,%;*("%'",9(.;("&';.@,9,@(*+,(;,"&'@(&',7(
!?+,9,(.;'\*(%(;.'D=,1":9,(*9,%*C,'*(@:,(*&(*+,(+%==C%9N;(&)("%'",97(
(
!?9,%*C,'*;(*+%*(%9,(%=9,%@W(&'(C%9N,*(+%$,(%(=&*(&)(;.@,(,X,"*;("%:;.'D(@%C%D,(*&('&'1
*:C&9%=(",==;B(",==:=%9(%-&-*&;.;7(
(
FZ?HIJ3<?FIZ(
Z,G(%--9&%"+Y(!"#$"%&'()*+,-'%.,/)$(0*(*,*#-,"1+.)'(
?79:&%'@"AB0&C'D"AB0&C'E'&79:&%)F"A&0&CG&H23A4$7)$3I)239'
J0"K&%7"939'/$9L05A3'6&'M3%2&>503'NJ/MO'E'@$0&'P.-*'
M32:&>5%Q7'R:&7"78'M"52:&A"79%<'S&#%&&'
(
!@$%'*%D,;(
J,=.$,9W( L:9)%",( ]&%@.'D( H,=,%;,(
"L-,".>"(*%9D,*(
"?9%';-&9*(.'*&(
/.=%W,9;(
"Z&(-&*,'#%=(
"Z&(%DD9,D%#&'(
"(O.'.C.[,(
&-;.'.[%#&'(
"F'"&9-&9%#&'(
C,*+&@(
"!/;&9-#&'(
C,*+&@(
"L&=:/.=.*W(
"]&'D1*,9C(
%"#&'(
!"#$%&'T)'L"+,C,(&)(%(
'%'&-%9#"=,(4^67(
<&C-&','*;(
Z!ZI8FIE!H?F<]_L(
F*( .;( %( -%9#"=,( /,*G,,'( US( %'@( VSS'C( .'(
;.[,()&9(C,@."%=(%--=."%#&';(G+."+(.;(:;,@(
*&(*9%';-&9*(%'@(9,=,%;,(%(@9:D7(
J,>'.#&'(
I/`,"#$,;(
!].-&;&C,;(
!E_K(
!?%9D,*(=.D%'@(
(
!aE9&bJ9:D(
?&(.C-9&$,Y(
!8.&@.;*9./:#&'(
!E+%9C%N.',#";(
FO!K_L(H_2_H_Z<_L(
4R6(c%'%+%'B(J7B(d(e,.'/,9DB(H7(%7(aVSSSb7(?+,(+%==C%9N;(&)("%'",97(2)..3(4553(678757(4V6(J%'+.,9B(27B(d(E9f%*B(g7(aVSR0b7(L*9%*,D.,;(*&(.C-9&$,(*+,(_EH(,X,"*()&9(*+,(
@,=.$,9W(&)(%'#1"%'",9('%'&C,@.".',;B(2,*+)"(2)..(9(:0+"#)*;0"#*<)*/3(=3(487(4U6(_*:/.";(<&9-&9%#&'(+M-Yhh,*:/.";7"&Ch/9,%;*1"%'",9h(aUSh0hVSR0b(4^6(iG."N,B(K7B(
O%';&&9.B(K7B(d(j,X,9WB(<7(aVSRVb7(3#=.[.'D(*+,()&=%*,(9,",-*&9()&9(%"#$,(*%9D,#'D(&)("%'",9('%'&*+,9%-,:#";7(>,*#(?);0)@'3(A(406(<%/9,9%B(L7B(d(Jk,[1*&99:/.%B(!7(
aVSRSb7(E9&)l9C%"&;(Y(-%;%@&(B(-9,;,'*,(W():*:9&B(B*C(D%E<7B(45F3(=578=4G7((456(L%.)B(O7(e7(aVSSTb7(?%9D,#'D("%'",9;(.'(*+,(D%;*9&.'*,;#'%=(*9%"*Y(H&=,(&)("%-,".*%/.',7(
H*+#I,"&)/'(,*$(IJ)",-K3(=3(=L8G4(4Q6(3,'&B(c7B(m.W&;%G%B(m7B(d(m%'.G%B(Z7(aVSSQb7(E+%9C%"&D,'&C.";(&)(D,C".*%/.',Y("%'(D,',#"(;*:@.,;(=,%@(*&(*%.=&91C%@,(
*+,9%-Wn(M"01'J(N#%"*,.(#O(2,*+)"3(L73(4G68464C((4P6(L.'D+B(!7B(J.='%G%[B(27B(d(L%+&&B(L7(m7(aVSRRb7(]&'D(".9":=%#'D(=,"#'("&'`:D%*,@(-%"=.*%A,=(=&%@,@(C%D',#"(
'%'&-%9#"=,;Y(!(',G(*+,9%'&;#"(%$,':,()&9(=,:N,C.%(*+,9%-WC(!P#Q(H>R3(F7(4T6(Kavallaris, M. (2010). Microtubules and resistance to tubulin-binding agents. Nature
Reviews. Cancer, 10, 194–204 4RS6((?&/.%\;(8,9'%=(8=&D(+M-Yhh*&/.%;/,9'%=7*W-,-%@7"&Ch/=&DhVSRVhSQhA,=&@%1C,"+%'.;C1&)1%"#&'7+*C=(aUShS0hVSR0b((
!J,"9,%;,(&)(*+,(-c((((((((9,=,%;,(&)(=%"*%*,7(
!c.D+,9(*,C-,9%*:9,(((((((()%;*,9(C,*%/&=.;C;7(
!_EH(,X,"*(
(((((((((((((C%`&9(-,9C,%/.=.*W(
<&CC&'("+%9%"*,9.;#";(
8H_!L?(<!Z<_H(
E%9#":=%9("+%9%"*,9.;#";(
!'D.&D,',;.;(*&(@,"9,%;,(+W-&A.%7(
!8H<!(((((((*:C&9(;:--9,;;&9(D,',(.;(C:*%*,@(
!c,9Vh',:(9,",-*&9((((((((&$,91,A-9,;;,@(
!"#$%&'U)'O&9-+&=&DW(&)(/9,%;*(
"%'",9(",==4U67(
!"#$%&'P)'<+%'D,;(.'(*+,(;:99&:'@.'D;(=,%@.'D(*&(_EH(,X,"*4V67(
<IZ<]3LFIZL(
E9&@9:D;(,'"%-;:=%*,@(.'('%'&-%9#"=,(%9,(D&&@()&9Y(
!?%9D,*1;-,".>"(((((((((((((_EH(,X,"*(.'(*+,($,;;,=;(&)(*:C&9;(;:99&:'@.'D;7((
(((((((((((((((((((((((((((((((((((((((((((((F'*,9%"#&'(*&(c,9Vh',:(&)(/9,%;*("%'",9(",==;7((
!!"#$%*,(*+,(-9&@9:D("=&;,(*&(*+,(*:C&9((((((((%".@."(-c7(
!!$&.@(*&A."(;.@,(,X,"*;(*&(o'&9C%=p(",==;7(
!_'"%-;:=%*,(+W@9&-+&/."(%'@(+W@9&-+.=."(a-9&b@9:D;7(
(
?&(%""&C-=.;+(*+%*B(*+,('%'&-%9#"=,(+%;(*&(/,Y(
!].-&;&C,("&$,9,@(G.*+(E_K(*&(%$&.@(&-;.'.[%#&'7(
!F*("%'(+%$,(%(/.D(;.[,((((((((C%A7(VSS('C((((((((_EH(,X,"*7(
!].D%'@(&)(c,9Vh',:(%M%"+,@(*&(;:9)%",(&)(*+,(ZE7((
Paclitaxel
!"#$%&'V7(L*%/.=.[%#&'(&)(
C."9&*:/:=,(@&',(/W(
-%"=.*%A,=4T67((
1 / 1 100%